Back to Search
STEVEN ALBERTS, M.D.
M.D.
Medical Oncology Physician
NPI: 1780660209Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
100995(WI)34443(MN)
Research & Publications (20)
Updated options for liver-limited metastatic colorectal cancer.
PMID 19064408·Clin Colorectal Cancer·2008
6-review
Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.
PMID 19023677·J Gastrointest Cancer·2007
3-trial
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.
PMID 17681103·Clin Colorectal Cancer·2007
3-trial
Therapeutic Advances in GI Malignancies--Fifth Annual Conference. 13-14 July 2007, Newport Beach, CA, USA.
PMID 17899484·IDrugs·2007
8-other
Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
PMID 19065716·J Gastrointest Cancer·2007
3-trial
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
PMID 15558814·Cancer·2005
3-trial
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.
PMID 16085692·Ann Oncol·2005
3-trial
N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.
PMID 16197625·Clin Colorectal Cancer·2005
3-trial
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
PMID 16230673·J Clin Oncol·2005
3-trial
Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
PMID 15611509·J Clin Oncol·2004
3-trial
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.
PMID 12649105·Ann Oncol·2003
3-trial
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.
PMID 12056705·Ann Oncol·2002
3-trial
CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study.
PMID 12794246·Int J Gastrointest Cancer·2002
3-trial
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.
PMID 11432620·Ann Oncol·2001
3-trial
Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
PMID 11295624·Urology·2001
8-other
Intrahepatic therapy for resected hepatic metastases from colorectal carcinoma.
PMID 11204664·Oncology (Williston Park)·2000
6-review
Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis?
PMID 19250258·Colorectal Dis·2010
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1780660209
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile